Adaptive Randomization of Neratinib in Early Breast Cancer
David Harrington1, Giovanni Parmigiani1
1Dana–Farber Cancer Institute, Boston, MA
The New England Journal of Medicine
|January 20, 2017
Abstract
No abstract available in PubMed .
More Related Videos
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
1.3K
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.5K
